Differential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
2010 · Journal of Translational Medicine · 224 citations
https://doi.org/10.1186/1479-5876-8-39
R
Ramin Nazarian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
3.7K
Citations
17
h-index
20
i10-index
Ramin Nazarian is an academic researcher from Massachusetts General Hospital. The author has contributed to research in topics: Melanoma and MAPK Pathways & Synthesis and biological activity & Protein Degradation and Inhibitors. The author has an h-index of 17, co-authored 49 publications.
ORCID: 0009-0001-7143-3095Papers by this author
worksMEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer
2019 · Prostate Cancer and Prostatic Diseases · 93 citations
https://doi.org/10.1038/s41391-019-0134-5
Supplementary Material for: Increased Bone Morphogenetic Protein Signaling in the Cutaneous Vasculature of Patients with Calciphylaxis
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.5584729
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat